Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Prostatic Neoplasms, Castration-Resistant × radium Ra 223 dichloride × Clear all

Status

Completed 4 Withdrawn 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4 Prostatic Neoplasms, Castration-Resistant 1 Multiple Myeloma 1

Interventions

enzalutamide 2 apalutamide 2 Abiraterone Acetate 2 radium Ra 223 dichloride 1 abiraterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03325127 2018-10-31

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Bayer

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡